191 related articles for article (PubMed ID: 22388620)
1. Gallium-labelled peptides for imaging of inflammation.
Roivainen A; Jalkanen S; Nanni C
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S68-77. PubMed ID: 22388620
[TBL] [Abstract][Full Text] [Related]
2. The untapped potential of Gallium 68-PET: the next wave of ⁶⁸Ga-agents.
Smith DL; Breeman WA; Sims-Mourtada J
Appl Radiat Isot; 2013 Jun; 76():14-23. PubMed ID: 23232184
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of a dual sstr2 and integrin α
Liu B; Zhang Z; Wang H; Yao S
Bioorg Med Chem; 2019 Nov; 27(21):115094. PubMed ID: 31540828
[TBL] [Abstract][Full Text] [Related]
4. PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.
Autio A; Ujula T; Luoto P; Salomäki S; Jalkanen S; Roivainen A
Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1918-25. PubMed ID: 20523988
[TBL] [Abstract][Full Text] [Related]
5. Gallium-68 complex of a macrobicyclic cage amine chelator tethered to two integrin-targeting peptides for diagnostic tumor imaging.
Ma MT; Neels OC; Denoyer D; Roselt P; Karas JA; Scanlon DB; White JM; Hicks RJ; Donnelly PS
Bioconjug Chem; 2011 Oct; 22(10):2093-103. PubMed ID: 21877750
[TBL] [Abstract][Full Text] [Related]
6. Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer.
Aalto K; Autio A; Kiss EA; Elima K; Nymalm Y; Veres TZ; Marttila-Ichihara F; Elovaara H; Saanijoki T; Crocker PR; Maksimow M; Bligt E; Salminen TA; Salmi M; Roivainen A; Jalkanen S
Blood; 2011 Sep; 118(13):3725-33. PubMed ID: 21821708
[TBL] [Abstract][Full Text] [Related]
7. Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK).
Simeček J; Notni J; Kapp TG; Kessler H; Wester HJ
Mol Pharm; 2014 May; 11(5):1687-95. PubMed ID: 24669840
[TBL] [Abstract][Full Text] [Related]
8.
Chen CJ; Chan CH; Lin KL; Chen JH; Tseng CH; Wang PY; Chien CY; Yu HM; Lin WJ
Nucl Med Biol; 2019; 68-69():22-30. PubMed ID: 30578136
[TBL] [Abstract][Full Text] [Related]
9. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
Li ZB; Chen K; Chen X
Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838
[TBL] [Abstract][Full Text] [Related]
10. Gallium-68 PET: a new frontier in receptor cancer imaging.
Al-Nahhas A; Win Z; Szyszko T; Singh A; Nanni C; Fanti S; Rubello D
Anticancer Res; 2007; 27(6B):4087-94. PubMed ID: 18225576
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor PET imaging with Gallium-68 labeled peptides.
Win Z; Al-Nahhas A; Rubello D; Gross MD
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):244-50. PubMed ID: 17464267
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
Shokeen M; Anderson CJ
Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing osteomyelitis.
Ujula T; Salomäki S; Virsu P; Lankinen P; Mäkinen TJ; Autio A; Yegutkin GG; Knuuti J; Jalkanen S; Roivainen A
Nucl Med Biol; 2009 Aug; 36(6):631-41. PubMed ID: 19647169
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
15. Expanding the Applicability of the Metal Labeling of Biomolecules by the RIKEN Click Reaction: A Case Study with Gallium-68 Positron Emission Tomography.
Nakamoto Y; Pradipta AR; Mukai H; Zouda M; Watanabe Y; Kurbangalieva A; Ahmadi P; Manabe Y; Fukase K; Tanaka K
Chembiochem; 2018 Oct; 19(19):2055-2060. PubMed ID: 30066425
[TBL] [Abstract][Full Text] [Related]
16. A monoreactive bifunctional triazacyclononane phosphinate chelator with high selectivity for gallium-68.
Simeček J; Zemek O; Hermann P; Wester HJ; Notni J
ChemMedChem; 2012 Aug; 7(8):1375-8. PubMed ID: 22693018
[No Abstract] [Full Text] [Related]
17. PET imaging of αvβ₃ integrin expression in tumours with ⁶⁸Ga-labelled mono-, di- and tetrameric RGD peptides.
Dijkgraaf I; Yim CB; Franssen GM; Schuit RC; Luurtsema G; Liu S; Oyen WJ; Boerman OC
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):128-37. PubMed ID: 20857099
[TBL] [Abstract][Full Text] [Related]
18. In vivo preclinical assessment of novel
Dénes N; Kis A; Szabó JP; Jószai I; Hajdu I; Arató V; Enyedi KN; Mező G; Hunyadi J; Trencsényi G; Kertész I
Appl Radiat Isot; 2021 Aug; 174():109778. PubMed ID: 34004593
[TBL] [Abstract][Full Text] [Related]
19. Does imaging αvβ3 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?
Rylova SN; Barnucz E; Fani M; Braun F; Werner M; Lassmann S; Maecke HR; Weber WA
J Nucl Med; 2014 Nov; 55(11):1878-84. PubMed ID: 25278514
[TBL] [Abstract][Full Text] [Related]
20. Dual-Integrin α
Iagaru A
J Nucl Med; 2017 Oct; 58(10):1706. PubMed ID: 28280224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
